<img alt="" src="https://secure.soil5hear.com/223550.png" style="display:none;">
Select Models

CDX

SK-MEL-5

Tumor indication

Skin

Tumor subtype

Malignant Melanoma

Description

SK-MEL-5 (Melanoma CDX Model) 

The SK-MEL-5 line was derived from a metastatic melanoma lesion. It carries the BRAF V600E mutation, a common driver in melanoma. SK-MEL-5 has been extensively applied in targeted therapy development. Its reproducible growth ensures reliability in translational melanoma research. 

Key Features: 

  • Derived from metastatic melanoma. 
  • BRAF V600E mutation. 
  • Strong MAPK pathway activation. 
  • Reliable xenograft tumorigenicity. 

Applications: 
SK-MEL-5 is used in drug discovery targeting BRAF and MEK pathways. Researchers employ it in biomarker validation and resistance mechanism studies. It is a standard melanoma model for preclinical targeted therapy testing. Its defined genetics make it suitable for precision oncology pipelines.

Details

Tumor indication
Skin
Tumor subtype
Malignant Melanoma
Organism
Human
Mouse sex
Female
Lumin data
Proteomics, RNA-Seq, WES

Mutated genes

Select a gene to see the variants recorded for this line.

BRAF TERT

Request this cell line